Can I invest in SIP and Lumpsum in Nippon India Nifty Pharma ETF Direct Growth?

Yes, you can invest both lumpsum and SIP in Nippon India Nifty Pharma ETF. Minimum lumpsum investment Nippon India Nifty Pharma ETF is ₹1,000 and minimum SIP amount is 0% . Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.

What is the NAV of Nippon India Nifty Pharma ETF Direct Growth?

The latest NAV (Net Asset Value) of Nippon India Nifty Pharma ETF is Nippon India Nifty Pharma ETF is ₹20.81 as on 2025-03-07.

Which are the biggest stock holdings of Nippon India Nifty Pharma ETF?

The 5 biggest stock holdings of Nippon India Nifty Pharma ETF are: Sun Pharma.Inds. (24.69%), Cipla (11.11%), Divi's Lab. (9.99%), Dr Reddy's Labs (9.77%), Lupin (6.59%)

What are the top sectors Nippon India Nifty Pharma ETF invests in?

A majority of Nippon India Nifty Pharma ETF 's AUM worth ₹809.18 (Cr) is invested in these 3 top sectors: Pharmaceuticals & Biotech : 99.94% Debt : 0.04% Cash & Others : 0.02%

Mutual Funds
Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

ETFs Fund

Invest Now

NAV
20.81(-0.22%)
Fund Size (CR)
₹866.14
Expense Ratio
0.21
Scheme Type
Passive Fund
Value Research

Min. investment
₹1,000
Minimum Additional Investment
₹0
Minimum SIP Investment
₹undefined
Minimum Withdrawal
₹0
Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment
0%
Return Since Launch
10.53%

Absolute Return: -8.50%

Annualized Return: 0%

Basic Details

Scheme Manager

Jitendra Tolani

Bench Mark

Nifty Pharma TRI

Type

OPEN

Lumpsum Returns

Period Invested For	₹10,000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	28 February 2025	10284.60	2.85%	-	2.24%	73/241
1 Month	7 February 2025	9232.80	-7.67%	-	-3.91%	194/236
3 Month	6 December 2024	9099.12	-9.01%	-	-6.99%	117/232
6 Month	6 September 2024	8853.80	-11.46%	-	-5.04%	144/222
1 Year	7 March 2024	10656.14	6.56%	6.56%	6.64%	63/201
3 Year	7 March 2022	16495.95	64.96%	18.14%	14.74%	27/127
5 Year	-	-	0%	-	16.10%	-/-
Since Inception	6 July 2021	14439.83	44.40%	10.53%	13.24%	140/241

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For	₹10,000 Invested on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	1 April 2024	1,20,000	116208.23	-3.16%	-3.16%
3 Year	1 April 2022	3,60,000	476537.52	32.37%	9.80%
5 Year	-	-	-	-	-
10 Year	-	-	-	-	-

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

Investment type
Scheme based

SIP
Lumpsum

Monthly Investment (₹)

Expected Returns Rate (%)

Time Period (in Years)

Start your SIP now

Invested Amount
₹25,000
Estimated Returns
₹19,059

76%

Returns

Future value of your investment

₹44,059

Risk Ratios

4.96%

Standard Deviation

1.00%

Beta

0.57%

Sharpe Ratio

0.02%

Treynor's Ratio

-0.24%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in	% of Total Holdings	Quantity	Value (Cr)	Asset Type	Segment
Sun Pharma.Inds.	24.69%	1253839	199.77	Equity	Pharmaceuticals
Cipla	11.11%	638498	89.87	Equity	Pharmaceuticals
Divi's Lab.	9.99%	147504	80.84	Equity	Pharmaceuticals
Dr Reddy's Labs	9.77%	708441	79.10	Equity	Pharmaceuticals
Lupin	6.59%	279984	53.33	Equity	Pharmaceuticals
Aurobindo Pharma	4.24%	324429	34.33	Equity	Pharmaceuticals
Torrent Pharma.	3.97%	109063	32.15	Equity	Pharmaceuticals
Alkem Lab	3.54%	61655	28.65	Equity	Pharmaceuticals
Mankind Pharma	3.41%	120578	27.62	Equity	Pharmaceuticals
Zydus Lifesci.	3.14%	290297	25.45	Equity	Pharmaceuticals

Peer Comparison

Scheme Name	Value Research	Asset Size (Cr)	1M	3M	6M	1Y	3Y

News

Nippon India Mutual Fund Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 06 March 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under the following schemes. The amount of distribution (Rs per unit) on the face value of Rs 10 per unit will be:
Nippon India ELSS Tax Saver Fund ' Regular Plan ' Annual IDCW Option Regular & Direct Plan ' IDCW Option: 1.50 each.
Nippon India ELSS Tax Saver Fund ' Regular Plan ' IDCW Option: 2.50
Nippon India ELSS Tax Saver Fund ' Direct Plan ' IDCW Option: 3.00
Powered by Capital Market - Live News

Nippon India Mutual Fund Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 03 March 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under the following schemes. The amount of distribution (Rs per unit) on the face value of Rs 10 per unit will be:
Nippon India Equity Hybrid Fund ' Regular Plan ' IDCW Option & Direct Plan ' IDCW Option: 2.00 each.
Nippon India Equity Hybrid Fund ' Regular Plan ' Monthly IDCW Option & Direct Plan ' Monthly IDCW Option: 1.00 each
Nippon India Equity Hybrid Fund ' Regular Plan ' Quarterly IDCW Option: 1.75
Nippon India Equity Hybrid Fund ' Direct Plan ' Quarterly IDCW Option: 2.00
Powered by Capital Market - Live News

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 14 February 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the regular plan ' IDCW payout and direct plan ' IDCW payout of Nippon India Balanced Advantage Fund. The quantum of distribution will be Rs 0.2000 per unit under each plan / option as on the record date.
Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

21 June 2021

Total AUM (Cr)

₹809.18

Nippon India Nifty Pharma ETF is an ETFs Fund-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in 21 June 2021, this fund is managed by Jitendra Tolani. With assets under management (AUM) worth ₹809.18 (Cr), as of 7 March 2025, Nippon India Nifty Pharma ETF is categorized as a ETFs Fund within its segment. The fund has generated a return of 10.53% since its launch.
The current NAV of Nippon India Nifty Pharma ETF is ₹20.81, as on 7 March 2025. The fund's benchmark index is Nifty Pharma TRI. You can invest in Nippon India Nifty Pharma ETF via both lumpsum and SIP modes. The minimum SIP amount in the fund is - while the minimum lumpsum investment is ₹1,000.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
Nil The fund has generated 18.14% and undefined% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 99.96% in Equity, 0.06% in Debt and -0.02% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 99.94% in Pharmaceuticals & Biotech, 0.04% in Debt, 0.02% in Cash & Others

FAQs

How to Invest in Nippon India Nifty Pharma ETF Direct Growth?

Nippon India Nifty Pharma ETF is a popular fund in the ETFs Fund segment. The fund has generated a return of 10.53% since inception. Looking to invest in Nippon India Nifty Pharma ETF How about earning 1% extra return? All this is possible with m.Stock! Investing in Nippon India Nifty Pharma ETF is super easy and convenient with m.Stock. Here’s how you can begin:

Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
In the search bar, enter the fund name, in this case, Nippon India Nifty Pharma ETF
On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.

So, why wait? Invest in Nippon India Nifty Pharma ETF today and reap the benefits of this ETFs Fund fund!

How much returns has Nippon India Nifty Pharma ETF Direct Growth generated?

In the short term, i.e., 1 year, Nippon India Nifty Pharma ETF has generated annualised return of 6.56%. In the long-term, the fund has generated 18.14% and - in 3 and 5 years respectively. Since its inception, the fund has generated 10.53% returns.

What is the expense ratio of Nippon India Nifty Pharma ETF Direct Growth?

The expense ratio of Nippon India Nifty Pharma ETF Direct Growth is 0.21%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.

What is the AUM of Nippon India Nifty Pharma ETF Fund Direct Growth?

The Assets Under Management (AUM) of Nippon India Nifty Pharma ETF is ₹809.18 (Cr) as of 2025-03-07 AUM shows the fund’s popularity and is often indicative of fund strength.

How to redeem or withdraw money from Nippon India Nifty Pharma ETF Direct Growth?

Redeeming or selling units of Nippon India Nifty Pharma ETF is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.

To redeem from Nippon India Nifty Pharma ETF:

Login to your m.Stock account
In portfolio, your mutual fund investments will be visible under ‘MF’
Select the fund you wish to redeem from (in this case Nippon India Nifty Pharma ETF).
Click on ‘Redeem’ button
You have 2 options – redeem by units and redeem by value (you can only redeem free units)
Select units to be redeemed and click on submit.
Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).